Director Stock Option Grant for James Mulay at CG Oncology, Inc.

This filing reports the grant of a stock option to James Mulay, a director at CG Oncology, Inc. (CGON). The option, for 9,354 shares of common stock, was granted on June 4, 2026, with an exercise price of $56.09 per share and an expiration date of June 3, 2036. The option vests in twelve equal monthly installments starting from June 4, 2026, contingent upon Mr. Mulay's continuous service to the company. The transaction is classified as a grant of a derivative security (Director Stock Option) under SEC Form 4. The reporting owner is James Mulay, with the transaction occurring on June 4, 2026, and reported on June 5, 2026. The option is exercisable for common stock.